2009
DOI: 10.1111/j.1469-8749.2008.03225.x
|View full text |Cite
|
Sign up to set email alerts
|

Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation

Abstract: Neopterin has a short half-life and was useful for monitoring inflammation activity in a patient with relapsing-remitting encephalitis. CSF neopterin is a useful marker of inflammation in a broad range of acute and chronic CNS disorders, and is a significantly more sensitive marker of inflammation than CSF pleocytosis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
93
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 90 publications
(101 citation statements)
references
References 30 publications
8
93
0
Order By: Relevance
“…Other biomarkers, including CSF neopterin and oligoclonal bands (OCBs), are less specific, but they are still useful markers of immune activation or inflammation in the CNS. 2 Before the discovery of the NMDAR antibody biomarker, OCBs were used to support the hypothesis that encephalitis lethargica and immunemediated chorea encephalopathy syndrome were autoimmune diseases; these syndromes have subsequently been shown to be NMDAR encephalitis. [3][4][5] OCBs have also been useful in the identification of unusual variants of known autoimmune encephalopathy.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Other biomarkers, including CSF neopterin and oligoclonal bands (OCBs), are less specific, but they are still useful markers of immune activation or inflammation in the CNS. 2 Before the discovery of the NMDAR antibody biomarker, OCBs were used to support the hypothesis that encephalitis lethargica and immunemediated chorea encephalopathy syndrome were autoimmune diseases; these syndromes have subsequently been shown to be NMDAR encephalitis. [3][4][5] OCBs have also been useful in the identification of unusual variants of known autoimmune encephalopathy.…”
Section: Resultsmentioning
confidence: 99%
“…1,2 However, non-specific biomarkers are likely continue to be of clinical utility as they can alert the clinician to atypical variants of autoimmune encephalopathy or to potential autoimmune diseases yet to be fully defined. 6 Additionally, specific autoantibody tests are less widely available than OCBs and may have a longer processing time; given that early diagnosis and treat- ment can improve outcomes, OCBs are likely to continue to play a useful role.…”
Section: Discussionmentioning
confidence: 99%
“…CSF neopterin, which is produced secondary to a-or g-interferon stimulation, was included as an alternative to CSF pleocytosis because it has been shown to be a useful marker of central nervous system (CNS) inflammation. 9 Encephalopathy was defined as an altered or reduced level of consciousness and a change in personality or behavior or confusion lasting .24 hours. We did not use lethargy and irritability as sole features of encephalopathy because of the nonspecific nature of these features in sick children unless supported by EEG features of encephalopathy.…”
Section: Definitionsmentioning
confidence: 99%
“…2). Where avaiable, other biomarkers of CNS inflammation including CSF oligoclonal bands 37 and CSF neopterin 38 should or if unavailable CT with contrast EEG †Collect up to 10 mL, if able, in four tubes in adults and children, and up to 5 mL in a small child (<2 years old). ‡Formal cytological examination is required to reliably differentiate eosinophils from other leukocytes and identify malignant cells.…”
Section: First-line Investigation Of All Patients With Suspected/probmentioning
confidence: 99%